Arrowhead Pharma (ARWR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 09/30
| 09-2019 | 06-2019 | 03-2019 | 12-2018 | 09-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 67,975 | 56,270 | 35,934 | 12,037 | -54,451 |
| Depreciation Amortization | 5,508 | 4,039 | 2,684 | 1,021 | 5,082 |
| Accounts receivable | -334 | -1,717 | -13,095 | -2,841 | -260 |
| Accounts payable and accrued liabilities | 4,844 | 1,824 | 1,256 | 1,131 | -1,270 |
| Other Working Capital | 87,159 | 91,639 | 104,762 | 152,509 | -5,878 |
| Other Operating Activity | 7,883 | 7,170 | 17,158 | 4,428 | 9,553 |
| Operating Cash Flow | $173,035 | $159,225 | $148,698 | $168,285 | $-47,223 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -35,745 | -60,405 | -78,027 | -67,019 | -6,014 |
| PPE Investments | -12,001 | -4,170 | -947 | -738 | -1,421 |
| Investing Cash Flow | $-47,746 | $-64,575 | $-78,974 | $-67,756 | $-7,435 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -2,415 | -2,415 | -2,415 | -2,415 | -209 |
| Common Stock Issued | 68,797 | 66,964 | 64,197 | 61,526 | 60,216 |
| Other Financing Activity | 0 | 0 | 0 | 0 | -55 |
| Financing Cash Flow | $66,382 | $64,549 | $61,781 | $59,111 | $59,953 |
| Beginning Cash Position | 30,133 | 30,133 | 30,133 | 30,133 | 24,839 |
| End Cash Position | 221,804 | 189,332 | 161,639 | 189,773 | 30,133 |
| Net Cash Flow | $191,671 | $159,199 | $131,506 | $159,640 | $5,295 |
| Free Cash Flow | |||||
| Operating Cash Flow | 173,035 | 159,225 | 148,698 | 168,285 | -47,223 |
| Capital Expenditure | -12,001 | -4,170 | -947 | -738 | -1,421 |
| Free Cash Flow | 161,034 | 155,055 | 147,752 | 167,547 | -48,645 |